Yann Lecluse

Villejuif, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications

The ETO2 transcriptional cofactor maintains acute leukemia by driving a MYB/EP300-dependent stemness program.

The ETO2 transcriptional cofactor maintains acute leukemia by driving a MYB/EP300-dependent stemness program.

Journal: HemaSphere
Published: March 01, 2024

Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer.

Resistance to BRAF inhibition explored through single circulating tumour cell molecular profiling in BRAF-mutant non-small-cell lung cancer.

Journal: British journal of cancer
Published: July 02, 2023

High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia.

High caspase 3 and vulnerability to dual BCL2 family inhibition define ETO2::GLIS2 pediatric leukemia.

Journal: Leukemia
Published: March 04, 2022

Lyl-1 regulates primitive macrophages and microglia development.

Lyl-1 regulates primitive macrophages and microglia development.

Journal: Communications biology
Published: May 07, 2021

CDKN1A is a target for phagocytosis-mediated cellular immunotherapy in acute leukemia.

CDKN1A is a target for phagocytosis-mediated cellular immunotherapy in acute leukemia.

Journal: Nature communications
Published: May 06, 2021

Isolation of tumor-resident CD8+ T cells from human lung tumors.

Isolation of tumor-resident CD8+ T cells from human lung tumors.

Journal: STAR protocols
Published: January 25, 2021

Circulating tumor cell copy-number heterogeneity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors.

Circulating tumor cell copy-number heterogeneity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors.

Journal: NPJ precision oncology
Published: December 16, 2020

Erratum: Multimodal imaging for tumour characterization from micro- to macroscopic level using a newly developed dorsal chamber designed for long-term follow-up.

Erratum: Multimodal imaging for tumour characterization from micro- to macroscopic level using a newly developed dorsal chamber designed for long-term follow-up.

Journal: Journal of biophotonics
Published: July 21, 2020

Nfkbie-deficiency leads to increased susceptibility to develop B-cell lymphoproliferative disorders in aged mice.

Nfkbie-deficiency leads to increased susceptibility to develop B-cell lymphoproliferative disorders in aged mice.

Journal: Blood cancer journal
Published: November 22, 2019

Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell Leukemia.

Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell Leukemia.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 26, 2019

Multimodal imaging for tumour characterization from micro- to macroscopic level using a newly developed dorsal chamber designed for long-term follow-up.

Multimodal imaging for tumour characterization from micro- to macroscopic level using a newly developed dorsal chamber designed for long-term follow-up.

Journal: Journal of biophotonics
Published: June 03, 2019

Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in ALK-Rearranged Non-Small-Cell Lung Cancer.

Acquired Resistance Mutations to ALK Inhibitors Identified by Single Circulating Tumor Cell Sequencing in ALK-Rearranged Non-Small-Cell Lung Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 09, 2019
Showing 1-12 of 20

Last Updated: 09/26/2026